BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

NCT06414434 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Liposarcoma
Recurrent Liposarcoma
Metastatic Liposarcoma
Unresectable Liposarcoma
MDM2 Gene Amplification
Myxoid Liposarcoma
CIC-Rearranged Sarcoma

Interventions

DRUG: BTX-A51

Sponsor

Michael Wagner, MD

Collaborators

[object Object]